Wael A. A. Fadaly

Invasomes nanocarriers for targeted delivery of letrozole derivative: A novel strategy to mitigate breast cancer.

As a non-steroidal aromatase inhibitor, letrozole is primarily used for treating estrogen-dependent breast cancer (BC). However, the long-term use of letrozole is limited due to severe adverse effects, including increased risks of cardiovascular disease and osteoporosis. A new bis-triazole compound derived from letrozo...